MACKENZIE FINANCIAL CORP
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 919859
TORONTO ONTARIO, A6
Position in ACAD
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$10,646,872
+$8,391,111 QoQ
Shares Held
420,825
+315.3% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#51
of 354 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $499,025,453 across 60 Biotechnology names. ACAD ranks #11 (2.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in ACAD
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,646,872 | 420,825 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,255,761 | 101,337 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,529,788 | 57,274 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $1,138,638 | 53,357 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,150,910 | 53,357 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $969,675 | 58,379 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $937,042 | 51,065 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $280,408 | 18,232 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $323,375 | 19,900 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,067,594 | 57,739 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,658,772 | 52,979 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $281,735 | 13,519 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $566,704 | 23,662 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $251,002 | 13,337 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $232,288 | 14,591 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $553,164 | 33,812 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $487,753 | 34,617 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $458,799 | 18,943 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $260,427 | 11,158 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||